Navigation Links
Unigene's Oral PTH Phase 2 Proof-of-Concept Data to be Presented at Upcoming Scientific Conferences
Date:6/28/2012

BOONTON, N.J., June 28, 2012 /PRNewswire/ -- Unigene Laboratories, Inc. (OTCBB: UGNE), a leader in the design, delivery, manufacture and development of peptide-based therapeutics, today announced that data from the Company's oral parathyroid hormone (PTH) analog Phase 2 proof-of-concept trial results will be part of two presentations by Dr. Lorraine Fitzpatrick, Medicine Development Leader for GlaxoSmithKline (GSK), at prestigious scientific conferences. 

5th International Workshop on Advances in the Molecular Pharmacology and Therapeutics of Bone Disease

"(Mis)Adventures In Drug Discovery"

  • Date & Time: Thursday, June 28, 2012 at 11:30 a.m. GMT
  • Location:  St. Catherine's College, Oxford, UK
  • Focus: Examination of PTH secretory dynamics via the comparison of PK data from ronacaleret, oral PTH, and PTH 1-34 and 1-84 

GIOSEG 5th Meeting Skeletal Endocrinology

SESSION 4 - Anabolic Therapies for Osteoporosis – "New PTHs: Modalities, Duration, Combinations"

  • Date & Time: Friday, September 21, 2012 from 2:30 - 4:00 p.m. BST
  • Location: University of Brescia, Main Hall School of Medicine, Brescia, Italy
  • Focus: Examination of PTH secretory dynamics via the comparison of PK data from ronacaleret, oral PTH, and PTH 1-34 and 1-84

"We are extremely pleased Dr. Fitzpatrick has chosen to present the data from our oral PTH Phase 2 proof-of-concept trial at two highly prestigious scientific conferences," stated Nozer Mehta, Ph.D., Vice President of Research and Development for Unigene.  "Both presentations will serve to highlight data that strongly validate Unigene's proprietary Peptelligence™ technology and, importantly, that the oral delivery of PTH is technically feasible."

The Phase 2 proof-of-concept oral PTH study was conducted by Unigene
'/>"/>

SOURCE Unigene Laboratories, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
2. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
3. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
4. Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way
5. Ultragenyx Announces Phase 1 Results of UX001 in Hereditary Inclusion Body Myopathy (HIBM), a Rare Neuromuscular Disease
6. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
7. Isis Initiates Phase 2 Study of ISIS-APOCIIIRx in Patients with Hypertriglyceridemia
8. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
9. Results Reported for Phase Ib Open-Label Clinical Trial for the Treatment of Depression Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™
10. Pearl Therapeutics Phase 2b Twice-Daily Dosing Data Suggest Morning and Evening Benefit of PT003 in Patients with COPD
11. Adamas Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA for Arimenda™
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... 3, 2015   Today: A tidal wave ... has prompted The Addiction Advisor to create an ... just 5 minutes. The drug screening service, ... drug test for thirteen (13) of the most ... packaging with instructions and recommendations, parents are advised ...
(Date:6/3/2015)... Respiratory Equipment has won a 2015 American Package Design Award ... FDA on December 2, is the first co-packaging of generic ... Nebulizer for patients with cystic fibrosis. "This ... unique product offering of nebulized drug and device.  In creating ... also wanted to convey that the components suit each other. ...
(Date:6/3/2015)... 02, 2015 Research and Markets ( ... "The Future of Pharmaceutical Outsourcing" report ... in a desperate need to develop better drugs ... companies have been increasingly utilizing external resources to ... constantly streamlining their internal operation. Their outsourcing demands ...
Breaking Medicine Technology:The Drug Detective Is A Simple Test That Could Save Your Child's Life 2Kitabis Pak Wins American Package Design Award 2The Future of Pharmaceutical Outsourcing: 2015 Report 2
(Date:6/3/2015)... 03, 2015 A recent FDA ... on product labels underscores the importance of patients ... the American Society for Dermatologic Surgery Association. , ... warnings about the risks for serious injury if ... product labels already include information about risks, the ...
(Date:6/3/2015)... Save On Medical ( http://www.saveonmedical.com ) launched ... for health care procedures easier for patients on the ... and makes it easier to compare the prices and ... Now, when patients search for the procedure they need ... can see the provider’s price and Docometer quality scores ...
(Date:6/3/2015)... June 03, 2015 “ Harmony ” was ... takes a look at the latest and coolest applications on ... host of AppWatch and technology expert, conducted the app review ... that wants to improve some aspect of their life. , ... only for people with difficulties in their life. However, hypnotherapy ...
(Date:6/3/2015)... MD (PRWEB) June 03, 2015 On the ... a $13 billion industry by 2020 ( click here ... Markets), computer scientists believe Baltimore has the talent ... industry in which genetic code and other biological data are ... cure disease. “Baltimore contains all the elements of a ...
(Date:6/3/2015)... June 03, 2015 Array Health ... technology, has announced that CEO Jonathan Rickert will present ... on June 4, 2015. The session will address ... are disrupting traditional business models in health care, and ... , WHAT: Digital Transformation and the Health Care ...
Breaking Medicine News(10 mins):Health News:ASDSA Supports FDA Fillers Directive 2Health News:ASDSA Supports FDA Fillers Directive 3Health News:ASDSA Supports FDA Fillers Directive 4Health News:Save On Medical Launches New Mobile-Optimized Website 2Health News:An Application to Enjoy Hypnotherapy Sessions at Home was featured on NewsWatch Television 2Health News:Baltimore Poised to Become a World-Leading Hub of Multi-Billion Dollar Bioinformatics Industry 2Health News:Baltimore Poised to Become a World-Leading Hub of Multi-Billion Dollar Bioinformatics Industry 3Health News:Array Health’s CEO to Present at America’s Health Insurance Plans Institute 2015 2
... , , SAN FRANCISCO, July ... gay, lesbian, bisexual, and transgender civil rights organization, today announced ... on Saturday, July 25, 2009, at the Westin St. Francis ... Progress," speakers will discuss issues impacting the LGBT community,s strive ...
... , , , EATONTOWN, ... ), a leader in the emerging field of biologic products ... ended June 30, 2009 financial results will be released Wednesday, ... a conference call and webcast on Thursday, July 30, 2009, ...
... , , , , ... , , SAN DIEGO, July 23 /PRNewswire-FirstCall/ ... focused on developing products for minimally disruptive surgical treatments for the spine, announced today ... NuVasive reported second quarter revenue of $88.5 million, a 54.1% increase over ...
... , WASHINGTON, July 23 The Community Oncology ... cancer patients and community providers of cancer care, has responded in ... , "We strongly support President Obama,s ... and fix what is broken., Unfortunately, that is the exact opposite ...
... July 23 Omnicell, Inc. (Nasdaq: OMCL ), a leading provider ... quarter ended June 30, 2009. , , ... up $0.4 million or 0.8% from the first quarter of 2009, and down ... , Second quarter 2009 net income as reported ...
... , NORCROSS, Ga., July 23 Immucor, Inc. (Nasdaq: ... transfusion industry, today reported financial results for the fiscal fourth quarter ended May ... Financial Highlights , , Revenue for ... million in the same period last year. , ...
Cached Medicine News:Health News:Human Rights Campaign Announces Speakers at 25th Annual Bay Area Gala 2Health News:Human Rights Campaign Announces Speakers at 25th Annual Bay Area Gala 3Health News:Osteotech Announces Second Quarter 2009 Financial Results Release and Conference Call 2Health News:NuVasive Reports Second Quarter 2009 Financial Results 2Health News:NuVasive Reports Second Quarter 2009 Financial Results 3Health News:NuVasive Reports Second Quarter 2009 Financial Results 4Health News:NuVasive Reports Second Quarter 2009 Financial Results 5Health News:NuVasive Reports Second Quarter 2009 Financial Results 6Health News:NuVasive Reports Second Quarter 2009 Financial Results 7Health News:NuVasive Reports Second Quarter 2009 Financial Results 8Health News:NuVasive Reports Second Quarter 2009 Financial Results 9Health News:NuVasive Reports Second Quarter 2009 Financial Results 10Health News:NuVasive Reports Second Quarter 2009 Financial Results 11Health News:NuVasive Reports Second Quarter 2009 Financial Results 12Health News:The Community Oncology Alliance Responds to President Obama's Press Conference Comments Regarding Cancer Patients 2Health News:The Community Oncology Alliance Responds to President Obama's Press Conference Comments Regarding Cancer Patients 3Health News:The Community Oncology Alliance Responds to President Obama's Press Conference Comments Regarding Cancer Patients 4Health News:Omnicell Announces Second Quarter 2009 Results 2Health News:Omnicell Announces Second Quarter 2009 Results 3Health News:Omnicell Announces Second Quarter 2009 Results 4Health News:Omnicell Announces Second Quarter 2009 Results 5Health News:Omnicell Announces Second Quarter 2009 Results 6Health News:Omnicell Announces Second Quarter 2009 Results 7Health News:Omnicell Announces Second Quarter 2009 Results 8Health News:Omnicell Announces Second Quarter 2009 Results 9Health News:Omnicell Announces Second Quarter 2009 Results 10Health News:Omnicell Announces Second Quarter 2009 Results 11Health News:Omnicell Announces Second Quarter 2009 Results 12Health News:Immucor Announces Fiscal Fourth Quarter Results 2Health News:Immucor Announces Fiscal Fourth Quarter Results 3Health News:Immucor Announces Fiscal Fourth Quarter Results 4Health News:Immucor Announces Fiscal Fourth Quarter Results 5Health News:Immucor Announces Fiscal Fourth Quarter Results 6Health News:Immucor Announces Fiscal Fourth Quarter Results 7Health News:Immucor Announces Fiscal Fourth Quarter Results 8
... product solutions were developed to assist in ... To maximize use of existing capital equipment, ... the productivity of their employees, organizations are ... their valuable assets and ensure those assets ...
... Mobile Location-ID™ offers a for asset tracking electronically. ... to all the assets that will be tracked. ... equipped with a reader, antenna, and a portable ... small as 10 inches x 6 inches. One ...
Radianse indoor positioning supports healthcare asset management with a way to locate medical equipment, devices and other portable assets....
... provides hospitals with a suite ... all their supplies, drugs, assets, ... remove all manual compliance from ... accurately. iRIS, or Intelligent Radio-Frequency ...
Medicine Products: